## CLX: Clorox Company (The) - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%); PEG 3.35 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($96.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Hudson Bay Capital Management LP Makes New $8.57 Million Investment in The Clorox Company $CLX**
- Source: MarketBeat | 20251215T105909 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP has invested $8.57 million in The Clorox Company by purchasing 71,362 shares, representing about 0.06% ownership. This move follows Clorox beating its quarterly EPS estimates and setting FY2026 guidance, alongside a director's significant share purchase. Institutional investors and hedge funds own 78.53% of Clorox stock.

**2. Clorox (CLX) Rating: Citigroup Lowers Price Target to $109.00**
- Source: GuruFocus | 20251217T214001 | Somewhat-Bearish | Relevance: 100%
- Citigroup has reaffirmed its Neutral rating on Clorox (CLX) but has reduced its price target from $120.00 to $109.00, indicating a downward revision of 9.17% in the expected valuation. This adjustment by analyst Filippo Falorni follows a series of similar price target reductions by other firms like JP Morgan, Wells Fargo, and Morgan Stanley in recent months. Despite these adjustments, the average target price from 17 analysts suggests a potential upside for Clorox, and GuruFocus estimates a fair value for the stock above its current trading price.

**3. Clorox (NYSE:CLX) Price Target Lowered to $109.00 at Citigroup**
- Source: MarketBeat | 20251217T144308 | Somewhat-Bearish | Relevance: 100%
- Citigroup has lowered its price target for Clorox (NYSE:CLX) to $109 from $120, maintaining a "neutral" rating. This implies an 8.1% upside, despite the company recently beating EPS estimates but experiencing an 18.9% year-over-year revenue decline and setting FY2026 EPS guidance. Several other brokerages have also adjusted their price targets and ratings on Clorox.

**4. Jim Cramer on Clorox: “It’s a Terrific Day to Own Clorox (CLX)”**
- Source: Insider Monkey | 20251217T122800 | Somewhat-Bullish | Relevance: 100%
- Jim Cramer emphasized the importance of portfolio diversification, highlighting Clorox (CLX) as a valuable offset to speculative AI stocks. Despite Clorox being one of the S&P 500's worst performers this year, Cramer noted its strong brands like Burt's Bees and Hidden Valley Ranch, and an attractive 4.72% dividend yield, suggesting it might be at a generational bottom.

**5. Clorox Scentiva Scented Bleach Adds Cherry Blossom & Peach Scent**
- Source: The Clorox Company | 20251217T030759 | Bullish | Relevance: 100%
- Clorox is expanding its Scentiva Scented Bleach line by introducing a new Cherry Blossom & Peach scent, aiming to combine powerful cleaning with a delicate fragrance. This innovation addresses consumer preference for pleasant scents in cleaning products, broadening the appeal of their bleach offerings. The new scent builds on the success of previous Scentiva products like Lavender & Jasmine, providing a "no compromises" solution for consumers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $109 | $120 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($10.20M) |
| Sells | 11 ($0.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Long-term trend broken: trading 19.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +3.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.35 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($10.2M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.4B |
| Beta | 0.57 |
| 52W Range | $98.20 - $165.00 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.35 |
| Forward P/E | 15.0 |
| Current P/E | 17.0 |
| YoY Growth | 12.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.8% to 1.9% (+3.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.4% confirms short-term momentum alignment. Below SMA200 (0.81x), long-term trend not supportive. RSI neutral at 41. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.92% (CS: 43) | Neutral |
| RSI_14 | 40.6 | Neutral |
| MACD Histogram | 0.05 | Bullish |
| vs SMA20 | 0.979x | Below |
| vs SMA50 | 0.931x | Below |
| vs SMA200 | 0.810x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $101.51
- **Stop Loss:** $96.65 (4.8% risk)
- **Target:** $106.37 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 222
- **Position Value:** $22,535.22
- **Portfolio %:** 22.54%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*